You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BPDCN

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in United States (MB-102, Fludarabine, Cyclophosphamide)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • MB-102
    • +2 more
    • Duarte, California
    • +3 more
    Jul 12, 2022

    Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • CD123 targeted CAR-NK cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Aug 28, 2023

    AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

    Recruiting
    • AML
    • +4 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
    • +1 more
    May 10, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • +3 more
    • Gilbert, Arizona
    • +14 more
    Apr 20, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

    Active, not recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Tagraxofusp-erzs
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 8, 2022

    Acute Myeloid Leukemia Trial in Italy (tagraxofusp)

    Recruiting
    • Acute Myeloid Leukemia
    • Bergamo, Italy
    • +7 more
    Dec 17, 2021

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

    Not yet recruiting
    • Hematologic Malignancy
    • +10 more
    • Los Angeles, California
    • +28 more
    Jul 26, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • TregGraft (Orca-T)
    • Duarte, California
    • +13 more
    Oct 28, 2021

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Acute Myeloid Leukemia Trial in United States (SL-401)

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Acute Myeloid Leukemia
    • Duarte, California
    • +8 more
    Apr 6, 2020

    Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Houston (UCART123)

    Terminated
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • UCART123
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 29, 2019

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 30, 2021

    Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • XmAb14045
    • Jacksonville, Florida
    • +8 more
    Mar 4, 2022

    Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

    Active, not recruiting
    • Adult Acute Myeloid Leukemia in Remission
    • +12 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean

    Completed
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Seoul, Gang Nam, Korea, Republic of
        Samsung medical center
      Sep 1, 2020

      Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

      Terminated
      • Multiple Myeloma
      • SL-401/ Pomalidomide/ Dexamethasone
      • Duarte, California
      • +2 more
      Jan 13, 2022

      Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

      Completed
      • Blastic Plasmacytoid Dendritic Cell Neoplasm
      • Hematological Malignancies
        • (no location specified)
        Aug 4, 2016

        Leukemia Trial in Houston (Lorvotuzumab Mertansine (IMGN901))

        Completed
        Has Results
        • Leukemia
        • Lorvotuzumab Mertansine (IMGN901)
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Aug 24, 2018